MYELOPROLIFERATIVE NEOPLASM

Clinical trials for MYELOPROLIFERATIVE NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new MYELOPROLIFERATIVE NEOPLASM trials appear

Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 26 Not yet recruiting 1 Not yet finished but already full! 12 Completed 4 Terminated 1

New hope for blood cancer patients in Early-Stage trial

Disease control Not yet recruiting

This study is testing a new combination of two drugs, pacritinib and azacitidine, for people with a type of blood and bone marrow cancer called myelodysplastic syndrome (MDS). The first part of the study will find the safest dose. The second part will see if this dose helps contr…

Matched conditions: MYELOPROLIFERATIVE NEOPLASM

Phase: PHASE1, PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

MYELOPROLIFERATIVE NEOPLASM

Get alerted when new MYELOPROLIFERATIVE NEOPLASM trials appear

New hope for blood cancer patients in Early-Stage trial